DE19675047I2 - Pharmazeutische Zusammensetzung mit einem Gehalt an 4-amino-1-hydroxybutan-1, 1-biphosphonsaeure - Google Patents

Pharmazeutische Zusammensetzung mit einem Gehalt an 4-amino-1-hydroxybutan-1, 1-biphosphonsaeure

Info

Publication number
DE19675047I2
DE19675047I2 DE1996175047 DE19675047C DE19675047I2 DE 19675047 I2 DE19675047 I2 DE 19675047I2 DE 1996175047 DE1996175047 DE 1996175047 DE 19675047 C DE19675047 C DE 19675047C DE 19675047 I2 DE19675047 I2 DE 19675047I2
Authority
DE
Germany
Prior art keywords
hydroxybutane
amino
pharmaceutical composition
composition containing
biphosphonic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE1996175047
Other languages
English (en)
Inventor
Sergio Rosini
Giorgio Staibano
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Istituto Gentili SpA
Original Assignee
Istituto Gentili SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26325111&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE19675047(I2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from IT8220781A external-priority patent/IT1201087B/it
Application filed by Istituto Gentili SpA filed Critical Istituto Gentili SpA
Application granted granted Critical
Publication of DE19675047I2 publication Critical patent/DE19675047I2/de
Active legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/3804—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
    • C07F9/3839—Polyphosphonic acids
    • C07F9/3856—Polyphosphonic acids containing halogen or nitro(so) substituents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/3804—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
    • C07F9/3839—Polyphosphonic acids
    • C07F9/3873—Polyphosphonic acids containing nitrogen substituent, e.g. N.....H or N-hydrocarbon group which can be substituted by halogen or nitro(so), N.....O, N.....S, N.....C(=X)- (X =O, S), N.....N, N...C(=X)...N (X =O, S)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE1996175047 1982-04-15 1983-04-12 Pharmazeutische Zusammensetzung mit einem Gehalt an 4-amino-1-hydroxybutan-1, 1-biphosphonsaeure Active DE19675047I2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT8220781A IT1201087B (it) 1982-04-15 1982-04-15 Bifosfonati farmacologicamente attivi,procedimento per la loro preparazione e relative composizioni farmaceutiche
IT140383 1983-02-16

Publications (1)

Publication Number Publication Date
DE19675047I2 true DE19675047I2 (de) 2003-06-12

Family

ID=26325111

Family Applications (2)

Application Number Title Priority Date Filing Date
DE19833313049 Granted DE3313049A1 (de) 1982-04-15 1983-04-12 Pharmakologisch wirksame biphosphonate, verfahren fuer ihre herstellung und diese enthaltende pharmazeutische zusammensetzungen
DE1996175047 Active DE19675047I2 (de) 1982-04-15 1983-04-12 Pharmazeutische Zusammensetzung mit einem Gehalt an 4-amino-1-hydroxybutan-1, 1-biphosphonsaeure

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE19833313049 Granted DE3313049A1 (de) 1982-04-15 1983-04-12 Pharmakologisch wirksame biphosphonate, verfahren fuer ihre herstellung und diese enthaltende pharmazeutische zusammensetzungen

Country Status (1)

Country Link
DE (2) DE3313049A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1195993B (it) * 1984-01-12 1988-11-03 Gentili Ist Spa Forme farmaceutiche a base di difosfonati
DE3434667A1 (de) * 1984-09-21 1986-04-03 Henkel KGaA, 4000 Düsseldorf 4-dimethylamino-1-hydroxybutan-1,1-diphosphonsaeure, deren wasserloesliche salze, verfahren zu ihrer herstellung sowie ihre verwendung
US5591730A (en) * 1993-10-12 1997-01-07 The Regents Of The University Of California Inhibition of urinary calculi growth

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH9776A (en) * 1967-12-11 1976-03-17 M Francis Compositions for inhibiting anomalous deposition and mobilization of calcium phosphate in animal tissue and method of use
DE2405254C2 (de) * 1974-02-04 1982-05-27 Henkel KGaA, 4000 Düsseldorf Verwendung von 3-Amino-1-Hydroxypropan-1, 1-diphosphonsäure oder ihrer wasserlöslichen Salze bei der Beeinflußung von Calciumstoffwechselstörungen im menschlichen oder tierischen Körper
DE2745083C2 (de) * 1977-10-07 1985-05-02 Henkel KGaA, 4000 Düsseldorf Hydroxydiphosphonsäuren und Verfahren zu deren Herstellung
DE3016289A1 (de) * 1980-04-28 1981-10-29 Henkel KGaA, 4000 Düsseldorf Verfahren zur herstellung von omega -amino-1-hydroxyalkyliden-1,1-bis-phosphonsaeuren
US4330486A (en) * 1980-04-28 1982-05-18 University Of Iowa Reseach Foundation Bis(phosphonic acid) difluoromethane

Also Published As

Publication number Publication date
DE3313049C2 (de) 1991-07-25
DE3313049A1 (de) 1983-11-17

Similar Documents

Publication Publication Date Title
NO1998011I1 (no) Tiludronsyre
NL970038I1 (nl) Farmaceutisch preparaat dat een NH22-(CH2)3-C(PO3H2)2OH-verbinding bevat.
NL930032I2 (nl) 7-Amino-1-cyclopropyl-4-oxo-1,4-dihydronafyridine-3-carbozuren, werkwijzen ter bereiding ervan en deze bevattende geneesmiddelen.
PT73686A (pt) Pharmaceutical formulation
ZA813465B (en) Pharmaceutical composition
DE3484098D1 (de) Pharmazeutische zusammensetzungen.
DK397483A (da) Sorbitolholdige haarde bolsjer
FI831534L (fi) Oxikam-derivat innehaollande farmaceutiska kompositioner och deras framstaellningsfoerfarande
DE3382086D1 (de) Pharmazeutische mixtur.
IT1162879B (it) Composizioni farmaceutiche
DE3382112D1 (de) Pharmazeutische zusammensetzung.
GB2096889B (en) Pharmaceutical composition containing 6-amino-1-hydroxyhexane-1,1-diphosphonic acid
GB8305175D0 (en) Substituted thiopyranopyrimidine pharmaceutical compounds
ZA818221B (en) Pharmaceutical compounds
ATE36455T1 (de) Pharmazeutische zusammensetzungen.
DE19675047I2 (de) Pharmazeutische Zusammensetzung mit einem Gehalt an 4-amino-1-hydroxybutan-1, 1-biphosphonsaeure
DE3483900D1 (de) Pharmazeutische zusammensetzungen.
IL63595A (en) Diaryl-imidazole compounds,their manufacture and pharmaceutical compositions containing them
DE3176849D1 (en) Pharmaceutical composition comprising 4-carbamoyl-imidazolium-5-olate
DK575181A (da) Fluormethylthioeddikesyrefrbindelser
IL70233A0 (en) 2-heterocyclylthioalkyl-2-penem compounds,their manufacture and pharmaceutical compositions containing them
MX9202984A (es) Composiciones farmaceuticas que contienen salbutamol.
IL68477A0 (en) 7beta-acylamido-3-cephem-4-carboxylic acid compounds,their manufacture and pharmaceutical compositions containing them
FI830462A0 (fi) Mjoeldrygealkaloider, foerfarande foer deras framstaellning och dessa foereningar innehaollande farmaceutiska kompositioner
GB2080300B (en) Substituted pyrimidin-2-ones the salts thereof processes for their preparation and pharmaceutical compositions containing them